Anti-Human SLITRK6 Antibody (SAA0827), FITC

Catalog No.

FHK06811

Species reactivity

Human

Host species

Human

Isotype

IgG2, kappa

Clonality

Monoclonal

Conjugation

FITC

Target

SLITRK6, SLIT and NTRK-like protein 6

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q9H5Y7

Applications

ELISA, FCM, IF

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0827

Efficacy of Antibody Drug Conjugates Alone and in Combination with other Agents in Metastatic Urothelial Carcinoma: A Scoping Review., PMID:38993528

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma., PMID:37861407

Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review., PMID:35973928

Targeting advanced urothelial carcinoma-developing strategies., PMID:30844889

Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker., PMID:26944921

Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison., PMID:26317352

Transcriptional profiling of adult neural stem-like cells from the human brain., PMID:25514637

Document Download

Anti-Human SLITRK6 Antibody (SAA0827), FITC.pdf